# Biomat USA Inc – FDA Inspection, Oct 5, 2017

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/7c00e2d6-f09a-4b16-8f9f-76b2f27916f8
Source feed: FDA_Inspections

> FDA inspection 1027767 of Biomat USA Inc, October 05, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 640. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1027767
- Company Name: Biomat USA Inc
- Inspection Date: 2017-10-05
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1118882 - 2020-01-30
- FDA Inspection 930472 - 2015-06-17
- FDA Inspection 849552 - 2013-09-19
- [FDA Inspection 794880 - 2012-08-16](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/a4741885-e6dd-48db-82d6-ffc49ae2a190)
- FDA Inspection 655320 - 2010-02-11

## Related Officers

- [Company Rep](https://www.keypedia.com/people/kathryn-a-krentz/9523b161-3b81-4a1b-aaca-c0406d756ab4)

Company: https://www.keypedia.com/companies/biomat-usa-inc/767d7e84-d090-47ba-b786-6824e179856d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d